Insulin glargine

Insulin Analog

Brands

Basaglar

Insulin glargine Pen Injector

DosageBrandImage
1.5 ML insulin glargine 300 UNT/ML Pen InjectorGeneric
1.5 ML insulin glargine 300 UNT/ML Pen Injector [Toujeo]Generic
3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen InjectorGeneric
3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen Injector [Soliqua]Generic
3 ML insulin glargine 100 UNT/ML Pen InjectorGeneric
3 ML insulin glargine 100 UNT/ML Pen Injector [Basaglar]Generic
3 ML insulin glargine 100 UNT/ML Pen Injector [Lantus]Generic
3 ML insulin glargine 100 UNT/ML Pen Injector [Semglee]Generic
3 ML insulin glargine 300 UNT/ML Pen InjectorGeneric
3 ML insulin glargine 300 UNT/ML Pen Injector [Toujeo]Generic
Sensor 3 ML insulin glargine 100 UNT/ML Pen InjectorGeneric
Sensor 3 ML insulin glargine 100 UNT/ML Pen Injector [Basaglar]Generic

Insulin glargine desired effects:

  • Increased Glucose Transport into Cells
  • Increased Protein Synthesis
  • Increased Glycogenesis
  • Increased Lipogenesis
  • Decreased Glycogenolysis
  • Decreased Lipolysis

Insulin glargine drug classes:

  • Insulin Analog

Insulin glargine pharmacologic actions:

  • Hypoglycemic Agents

Insulin glargine mechanism of action:

  • Insulin Receptor Agonists
  • treatable

The content offered on Treatable.org is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Questions? Call or text: 859-651-7603

LegitScript approved
Copyright © Treatable 2023
Last updated: 5/13/2024, 8:14:19 AM